Lingjun Mao

Title: Innovations by Inventor Lingjun Mao

Introduction

Lingjun Mao is a notable inventor based in Hope, Rhode Island, who has made significant contributions to the field of biotechnology. He holds 2 patents that focus on the development of antisense oligonucleotides, which have potential applications in cancer treatment. His work is characterized by a commitment to advancing medical science through innovative solutions.

Latest Patents

Mao's latest patents include groundbreaking research on antisense oligonucleotides that inhibit the expression of HIF-1. The compounds RX-0047 and RX-0149 not only inhibit HIF-1 expression but also induce cytotoxicity in various cancer cell lines. Additionally, he has developed new antisense oligonucleotide compounds that inhibit the expression of human Akt-1, which also demonstrate cytotoxic effects in several cancer cell lines.

Career Highlights

Throughout his career, Lingjun Mao has worked with prominent companies in the biotechnology sector, including Rexahn Corporation and Rexahn Pharmaceuticals, Inc. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to significant advancements in cancer research.

Collaborations

Mao has collaborated with notable colleagues such as Heejeong Yoon and Young Bok Lee, further enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Lingjun Mao's innovative work in the development of antisense oligonucleotides showcases his dedication to improving cancer treatment options. His contributions to biotechnology are paving the way for future advancements in medical science.